PharmaEngine Statistics

Total Valuation

PharmaEngine has a market cap or net worth of TWD 13.48 billion. The enterprise value is 9.74 billion.

Market Cap	13.48B
Enterprise Value	9.74B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Aug 12, 2024

Share Statistics

PharmaEngine has 143.68 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	143.68M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	1.27%
Owned by Institutions (%)	5.13%
Float	93.39M

Valuation Ratios

The trailing PE ratio is 36.50 and the forward PE ratio is 11.33.

PE Ratio	36.50
Forward PE	11.33
PS Ratio	16.19
PB Ratio	3.38
P/TBV Ratio	n/a
P/FCF Ratio	32.87
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.24, with an EV/FCF ratio of 23.77.

EV / Earnings	26.33
EV / Sales	11.71
EV / EBITDA	24.24
EV / EBIT	24.81
EV / FCF	23.77

Financial Position

The company has a current ratio of 53.67, with a Debt / Equity ratio of 0.00.

Current Ratio	53.67
Quick Ratio	53.46
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.02
Interest Coverage	1,843.89

Financial Efficiency

Return on equity (ROE) is 9.48% and return on invested capital (ROIC) is 6.27%.

Return on Equity (ROE)	9.48%
Return on Assets (ROA)	6.17%
Return on Capital (ROIC)	6.27%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.21
Inventory Turnover	2.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.09% in the last 52 weeks. The beta is 0.65, so PharmaEngine's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-1.09%
50-Day Moving Average	93.26
200-Day Moving Average	94.21
Relative Strength Index (RSI)	42.33
Average Volume (20 Days)	2,082,642

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEngine had revenue of TWD 831.92 million and earned 370.14 million in profits. Earnings per share was 2.57.

Revenue	831.92M
Gross Profit	785.81M
Operating Income	392.75M
Pretax Income	451.10M
Net Income	370.14M
EBITDA	394.31M
EBIT	392.75M
Earnings Per Share (EPS)	2.57

Full Income Statement

Balance Sheet

The company has 3.74 billion in cash and 9.07 million in debt, giving a net cash position of 3.73 billion or 25.98 per share.

Cash & Cash Equivalents	3.74B
Total Debt	9.07M
Net Cash	3.73B
Net Cash Per Share	25.98
Equity (Book Value)	3.98B
Book Value Per Share	27.71
Working Capital	3.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 410.89 million and capital expenditures -908,000, giving a free cash flow of 409.98 million.

Operating Cash Flow	410.89M
Capital Expenditures	-908,000
Free Cash Flow	409.98M
FCF Per Share	2.85

Full Cash Flow Statement

Margins

Gross margin is 94.46%, with operating and profit margins of 47.21% and 44.49%.

Gross Margin	94.46%
Operating Margin	47.21%
Pretax Margin	54.22%
Profit Margin	44.49%
EBITDA Margin	47.40%
EBIT Margin	47.21%
FCF Margin	49.28%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.60%.

Dividend Per Share	1.50
Dividend Yield	1.60%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	58.21%
Buyback Yield	-0.03%
Shareholder Yield	1.57%
Earnings Yield	2.74%
FCF Yield	3.04%

Dividend Details

Stock Splits

The last stock split was on July 26, 2017. It was a forward split with a ratio of 1.1999616012.

Last Split Date	Jul 26, 2017
Split Type	Forward
Split Ratio	1.1999616012

Scores

PharmaEngine has an Altman Z-Score of 109.79.

Altman Z-Score	109.79
Piotroski F-Score	n/a